Should low bone mass be treated?

Paul D Miller

PubMed · 16334416

Should low bone mass be treated?

Abstract

More postemenopausal women with osteopenia fracture than those who have osteoporosis. Algorithms are being developed to enhance risk stratification to facilitate decisions when to treat in the osteopenic population. Evidence exists that osteoporosis agents can reduce fracture risk in the osteopenic population.

Explore related subjects

Body Mass Index Female Fractures, Bone Fractures, Spontaneous Humans Mass Screening Osteoporosis, Postmenopausal Practice Guidelines as Topic Primary Prevention Risk Assessment Risk Factors Severity of Illness Index United States Women's Health Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Paul D Miller. Should low bone mass be treated?. https://pubmed.ncbi.nlm.nih.gov/16334416/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

LongCriSP: a test for bump hunting in longitudinal data.

We propose an extension of the Harezlak and Heckman (J. Comput. Graph. Statist. 2001; 10(4): 713-729) test for detecting local extrema to the longitudinal data setting. We use penalized spline regression techniques (Statist. Sci. 1996; 11:89-102) to provide a computationally efficient method of testing for relatively large data sets. We estimate the p-values of our test, LongCriSP, with a smoothed bootstrap. Our simulation studies indicate that the test is generally conservative and has power exceeding 70 per cent at the alpha = 0.1 nominal level in most considered settings. Finally, we apply our testing procedure to the longitudinal measurements of body mass index of former prisoners of war in Vietnam and conclude that the mean population curve exhibits non-monotone behaviour.

Body Mass Index↗

PubMed2007

Commentary: The relationship between parity and overweight--a life course perspective.

Explore the source record for details and available documents.

Body Mass Index↗

PubMed2007

An estrogen metabolism-related polymorphism of the 17-alpha HSD gene is associated with perimenopausal body mass index.

In a cross-sectional study of 2,802 perimenopausal caucasian women, carriage of at least one mutated allele of the 17-alpha-hydroxysteroid dehydrogenase type 1 (17-alpha HSD) vlV A-->C single nucleotide polymorphism (SNP) was associated with a significantly increased body mass index (mean 24.3 +/- 4.4 kg/m(2) vs. 23.5 +/- 4.2 kg/m(2); P<.001), and obesity was more frequent among mutant allele carriers (P=.06; odds ratio 1.38; 95% confidence interval 0.97-1.95), providing evidence of 17-alpha HSD as a candidate gene of perimenopausal obesity.

Body Mass Index↗